T78.41 Arthus phenomenon

Name of the Condition

• Arthus phenomenon (ICD-10 Code: T78.41)

Summary

This code is used to document the Arthus phenomenon, a localized hypersensitivity reaction characterized by immune complex-mediated inflammation. It typically occurs at the site of antigen exposure, often following vaccination or injection of foreign proteins.

Causes

The Arthus phenomenon results from the deposition of antigen-antibody complexes in small blood vessels, triggering complement activation and inflammatory responses. Common triggers include repeated antigen exposure, such as with certain vaccines, medications, or biological products.

Risk Factors

• Prior exposure to the same antigen
• High antigen concentration at the injection site
• Impaired immune regulation
• Underlying inflammatory conditions

Symptoms

• Localized swelling and redness at the exposure site
• Pain or tenderness
• Skin necrosis or ulceration in severe cases
• Systemic symptoms (e.g., fever) are rare

Diagnosis

Diagnosis is based on clinical presentation and history of antigen exposure. Laboratory tests may show elevated inflammatory markers, but confirmation often relies on correlating symptoms with the timing and location of antigen administration.

Treatment Options

• Local cooling or anti-inflammatory measures
• Corticosteroids for severe inflammation
• Wound care for necrotic lesions
• Avoidance of the triggering antigen in future exposures

Prognosis and Follow-Up

Most cases resolve with supportive care, though localized tissue damage may persist. Follow-up is recommended to monitor for complications and prevent re-exposure to the causative antigen.

Complications

• Tissue necrosis or scarring
• Secondary infection
• Chronic inflammation at the site

Lifestyle & Prevention

• Avoid known triggering antigens
• Use alternative formulations or routes of administration when possible
• Monitor for early signs of reaction after exposure

When to Seek Professional Help

Seek medical attention if symptoms worsen, spread, or include systemic signs (e.g., fever, widespread rash), as these may indicate a more severe reaction.

Tips for Medical Coders

Document the specific antigen exposure (e.g., vaccine, medication) and clinical findings to support coding. Ensure the encounter type (e.g., initial, subsequent) aligns with the episode of care. This code is specific to localized immune complex reactions and should not be used for generalized allergic responses.